Nuveen’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.83M | Buy |
1,545,549
+626,586
| +68% | +$2.84M | ﹤0.01% | 1771 |
|
|
2026
Q1 | $4.14M | Sell |
918,963
-271,603
| -23% | -$1.42M | ﹤0.01% | 1961 |
|
|
2025
Q4 | $7.32M | Buy |
1,190,566
+465,670
| +64% | +$3.38M | ﹤0.01% | 1739 |
|
|
2025
Q3 | $5.24M | Sell |
724,896
-14,138
| -2% | -$83.9K | ﹤0.01% | 1884 |
|
|
2025
Q2 | $3.92M | Sell |
739,034
-437,649
| -37% | -$2.59M | ﹤0.01% | 1999 |
|
|
2025
Q1 | $10.4M | Sell |
1,176,683
-188,187
| -14% | -$2.26M | ﹤0.01% | 1530 |
|
|
2024
Q4 | $18.7M | Sell |
1,364,870
-62,318
| -4% | -$1.15M | 0.01% | 1229 |
|
|
2024
Q3 | $39.1M | Buy |
1,427,188
+48,964
| +4% | +$1.33M | 0.01% | 784 |
|
|
2024
Q2 | $33.7M | Sell |
1,378,224
-53,157
| -4% | -$1.17M | 0.01% | 824 |
|
|
2024
Q1 | $30.5M | Buy |
1,431,381
+381,436
| +36% | +$8.2M | 0.01% | 901 |
|
|
2023
Q4 | $20.1M | Buy |
1,049,945
+604,590
| +136% | +$10.5M | 0.01% | 1152 |
|
|
2023
Q3 | $7.14M | Sell |
445,355
-50,724
| -10% | -$965K | ﹤0.01% | 1677 |
|
|
2023
Q2 | $11.5M | Buy |
496,079
+275,802
| +125% | +$6.02M | ﹤0.01% | 1423 |
|
|
2023
Q1 | $5.12M | Sell |
220,277
-29,087
| -12% | -$591K | ﹤0.01% | 1875 |
|
|
2022
Q4 | $3.62M | Sell |
249,364
-37,016
| -13% | -$690K | ﹤0.01% | 2098 |
|
|
2022
Q3 | $5.46M | Sell |
286,380
-5,746
| -2% | -$132K | ﹤0.01% | 1850 |
|
|
2022
Q2 | $5.31M | Sell |
292,126
-142,397
| -33% | -$2.96M | ﹤0.01% | 1901 |
|
|
2022
Q1 | $11M | Sell |
434,523
-173,499
| -29% | -$4.44M | ﹤0.01% | 1578 |
|
|
2021
Q4 | $15.8M | Buy |
608,022
+36,997
| +6% | +$1.07M | ﹤0.01% | 1378 |
|
|
2021
Q3 | $19.3M | Sell |
571,025
-13,314
| -2% | -$442K | 0.01% | 1299 |
|
|
2021
Q2 | $17.9M | Sell |
584,339
-24,585
| -4% | -$710K | 0.01% | 1460 |
|
|
2021
Q1 | $18.5M | Buy |
608,924
+107,179
| +21% | +$3.04M | 0.01% | 1381 |
|
|
2020
Q4 | $9.92M | Buy |
501,745
+170,791
| +52% | +$2.76M | ﹤0.01% | 1716 |
|
|
2020
Q3 | $4.32M | Buy |
330,954
+2,078
| +0.6% | +$26.3K | ﹤0.01% | 1997 |
|
|
2020
Q2 | $3.73M | Buy |
328,876
+30,677
| +10% | +$436K | ﹤0.01% | 2060 |
|
|
2020
Q1 | $4.27M | Buy |
298,199
+6,565
| +2% | +$139K | ﹤0.01% | 1802 |
|
|
2019
Q4 | $7.94M | Sell |
291,634
-16,689
| -5% | -$459K | ﹤0.01% | 1727 |
|
|
2019
Q3 | $8.83M | Sell |
308,323
-365,618
| -54% | -$10.7M | ﹤0.01% | 1652 |
|
|
2019
Q2 | $18.7M | Buy |
673,941
+659,547
| +4,582% | +$18.6M | 0.01% | 1194 |
|
|
2019
Q1 | $478K | Hold |
14,394
| – | – | ﹤0.01% | 837 |
|
|
2018
Q4 | $418K | Hold |
14,394
| – | – | ﹤0.01% | 839 |
|
|
2018
Q3 | $662K | Buy |
14,394
+1,490
| +12% | +$66.3K | ﹤0.01% | 814 |
|
|
2018
Q2 | $482K | Hold |
12,904
| – | – | ﹤0.01% | 871 |
|
|
2018
Q1 | $381K | Hold |
12,904
| – | – | ﹤0.01% | 939 |
|
|
2017
Q4 | $443K | Hold |
12,904
| – | – | ﹤0.01% | 926 |
|
|
2017
Q3 | $467K | Hold |
12,904
| – | – | ﹤0.01% | 926 |
|
|
2017
Q2 | $333K | Sell |
12,904
-3,348
| -21% | -$71.1K | ﹤0.01% | 1007 |
|
|
2017
Q1 | $312K | Sell |
16,252
-878
| -5% | -$15.6K | ﹤0.01% | 1264 |
|
|
2016
Q4 | $286K | Sell |
17,130
-265
| -2% | -$4.79K | ﹤0.01% | 1413 |
|
|
2016
Q3 | $358K | Hold |
17,395
| – | – | ﹤0.01% | 1299 |
|
|
2016
Q2 | $532K | Sell |
17,395
-213
| -1% | -$7.4K | ﹤0.01% | 1163 |
|
|
2016
Q1 | $659K | Sell |
17,608
-233
| -1% | -$8.78K | ﹤0.01% | 1164 |
|
|
2015
Q4 | $770K | Sell |
17,841
-199
| -1% | -$8.41K | ﹤0.01% | 1160 |
|
|
2015
Q3 | $676K | Hold |
18,040
| – | – | ﹤0.01% | 1234 |
|
|
2015
Q2 | $613K | Buy |
18,040
+4,986
| +38% | +$170K | ﹤0.01% | 1308 |
|
|
2015
Q1 | $462K | Sell |
13,054
-6,800
| -34% | -$243K | ﹤0.01% | 1378 |
|
|
2014
Q4 | $676K | Sell |
19,854
-24,300
| -55% | -$862K | ﹤0.01% | 1302 |
|
|
2014
Q3 | $1.7M | Hold |
44,154
| – | – | 0.01% | 881 |
|
|
2014
Q2 | $1.72M | Hold |
44,154
| – | – | 0.01% | 888 |
|
|
2014
Q1 | $1.51M | Sell |
44,154
-7,270
| -14% | -$225K | 0.01% | 929 |
|
|
2013
Q4 | $1.08M | Sell |
51,424
-58,233
| -53% | -$1.47M | 0.01% | 1068 |
|
|
2013
Q3 | $2.58M | Sell |
109,657
-6,093
| -5% | -$173K | 0.02% | 705 |
|
|
2013
Q2 | $3.11M | Buy |
+115,750
| New | +$3.35M | 0.02% | 624 |
|
Other funds holding MYGN
VPC
Nuveen's MYGN Position: Q2 2026 in Review
Nuveen increased its Myriad Genetics (MYGN) stake by 68% in Q2 2026, buying an estimated $2.84M and bringing the position to 1,545,549 shares worth $8.83M. The position accounts for ﹤0.01% of the portfolio, ranked #1771.
Nuveen first reported a position in MYGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $39.1M in Q3 2024. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.
- Nuveen held 1,545,549 shares of Myriad Genetics worth $8.83M as of Q2 2026.
- Nuveen bought 626,586 Myriad Genetics shares in Q2 2026, an estimated $2.84M.
- Myriad Genetics made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1771 holding.
- Nuveen first reported a position in Myriad Genetics in Q2 2013 and has held it in 53 quarters since.
- Nuveen's Myriad Genetics position peaked at $39.1M in Q3 2024.
- 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.